IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
IQVIA (NYSE:IQV) has been awarded the 2024 Global Customer Value Leadership Award by Frost & Sullivan for excellence in AI quality and regulatory solutions for healthcare. The recognition is for IQVIA's Enterprise Quality Management System (eQMS), SmartSolve®, which simplifies quality and regulatory compliance processes. SmartSolve is an intelligence-driven platform that improves patient safety, enhances product quality, and maintains compliance.
The platform is powered by IQVIA Healthcare-grade AI™, designed to meet the precision, speed, and trust requirements of life sciences and healthcare. IQVIA's approach combines intelligence-driven simplification, integration, and automation to transform quality operations and drive efficiency for QA/RA professionals.
IQVIA (NYSE:IQV) ha ricevuto il 2024 Global Customer Value Leadership Award da Frost & Sullivan per l'eccellenza nelle soluzioni di qualità e regolamentazione basate sull'IA per la salute. Il riconoscimento è stato assegnato al SmartSolve®, il Sistema di Gestione della Qualità d'Impresa (eQMS) di IQVIA, che semplifica i processi di conformità alla qualità e alle normative. SmartSolve è una piattaforma guidata dall'intelligenza che migliora la sicurezza del paziente, aumenta la qualità del prodotto e mantiene la conformità.
La piattaforma è alimentata dall'IQVIA Healthcare-grade AI™, progettata per soddisfare i requisiti di precisione, velocità e fiducia delle scienze della vita e della sanità. L'approccio di IQVIA combina semplificazione, integrazione e automazione guidate dall'intelligenza per trasformare le operazioni della qualità e aumentare l'efficienza per i professionisti QA/RA.
IQVIA (NYSE:IQV) ha sido galardonada con el Premio a la Liderazgo Global en Valor al Cliente 2024 por Frost & Sullivan, por su excelencia en soluciones de calidad y regulaciones de IA para el sector sanitario. Este reconocimiento es para el SmartSolve®, el Sistema de Gestión de Calidad Empresarial (eQMS) de IQVIA, que simplifica los procesos de cumplimiento de calidad y regulaciones. SmartSolve es una plataforma impulsada por inteligencia que mejora la seguridad del paciente, eleva la calidad del producto y mantiene la conformidad.
La plataforma está impulsada por IQVIA Healthcare-grade AI™, diseñada para cumplir con los requisitos de precisión, rapidez y confianza en las ciencias de la vida y la atención médica. El enfoque de IQVIA combina simplificación, integración y automatización impulsadas por inteligencia para transformar las operaciones de calidad y aumentar la eficiencia para los profesionales de QA/RA.
IQVIA (NYSE:IQV)는 Frost & Sullivan로부터 의료 분야에서 AI 품질 및 규제 솔루션의 우수성에 대해 2024 글로벌 고객 가치 리더십 어워드를 수상했습니다. 이 인정은 IQVIA의 스마트솔브(SmartSolve®) 기업 품질 관리 시스템(eQMS)에 대한 것으로, 품질 및 규제 컴플라이언스 프로세스를 간소화합니다. 스마트솔브는 환자 안전성을 개선하고, 제품 품질을 향상시키며, 규제 준수를 유지하는 지능 기반 플랫폼입니다.
이 플랫폼은 생명 과학 및 의료 분야의 정밀성, 속도 및 신뢰성 요구 사항을 충족하도록 설계된 IQVIA 헬스케어 등급 AI™에 의해 구동됩니다. IQVIA의 접근 방식은 지능 기반의 단순화, 통합 및 자동화를 결합하여 품질 운영을 혁신하고 QA/RA 전문가를 위한 효율성을 높입니다.
IQVIA (NYSE:IQV) a reçu le Prix Mondial de Leadership en Valeur Client 2024 de Frost & Sullivan pour son excellence en matière de solutions de qualité et de réglementation basées sur l'IA pour le secteur de la santé. Cette reconnaissance concerne le SmartSolve®, le Système de Gestion de la Qualité d'Entreprise (eQMS) d'IQVIA, qui simplifie les processus de conformité en qualité et en réglementation. SmartSolve est une plateforme pilotée par l'intelligence qui améliore la sécurité des patients, renforce la qualité des produits et maintient la conformité.
La plateforme est alimentée par IQVIA Healthcare-grade AI™, conçue pour répondre aux exigences de précision, de rapidité et de confiance des sciences de la vie et de la santé. L'approche d'IQVIA allie simplification, intégration et automatisation pilotées par l'intelligence pour transformer les opérations de qualité et accroître l'efficacité pour les professionnels QA/RA.
IQVIA (NYSE:IQV) wurde von Frost & Sullivan mit dem 2024 Global Customer Value Leadership Award für herausragende Leistungen im Bereich KI-Qualitäts- und Regulierungslösungen im Gesundheitswesen ausgezeichnet. Die Auszeichnung gilt für das SmartSolve®, das Enterprise Quality Management System (eQMS) von IQVIA, das die Qualitätssicherungs- und Regulierungsprozesse vereinfacht. SmartSolve ist eine intelligenzbetriebene Plattform, die die Patientensicherheit verbessert, die Produktqualität steigert und die Compliance aufrechterhält.
Die Plattform wird durch die IQVIA Healthcare-grade AI™ betrieben, die darauf ausgelegt ist, die Anforderungen an Präzision, Geschwindigkeit und Vertrauen in den Lebenswissenschaften und im Gesundheitswesen zu erfüllen. IQVIAs Ansatz kombiniert intelligenzbetriebene Vereinfachung, Integration und Automatisierung zur Transformation der Qualitätsoperationen und zur Steigerung der Effizienz für QA/RA-Professionals.
- Recognition with the 2024 Global Customer Value Leadership Award from Frost & Sullivan
- SmartSolve platform simplifies quality and regulatory compliance processes
- AI-powered solution improves patient safety and enhances product quality
- Platform drives commercial efficiency and process effectiveness
- None.
Award Recognizes Leadership in AI Regulatory and Quality Solutions for Healthcare
Frost & Sullivan’s annual Customer Value Leadership Award recognizes the company that offers products or services that customers find superior in overall price, performance and quality. IQVIA was awarded this recognition for its Enterprise Quality Management System (eQMS), SmartSolve®, which serves as a single source of truth ecosystem that simplifies the complexity of quality and regulatory compliance.
SmartSolve is an intelligence-driven platform that enables quality assurance and regulatory affairs professionals to improve patient safety, enhance product quality, drive commercial efficiency, process effectiveness and maintain compliance. Similar to all IQVIA AI-powered solutions, IQVIA’s SmartSolve’s eQMS platform is grounded in IQVIA Healthcare-grade AI™, AI engineered to meet the level of precision, speed and trust required for life sciences and healthcare.
“It is an honor to be recognized for our transformative artificial intelligence efforts in the quality and regulatory space,” said Susan Hill, vice president of Global Product Management, Digital Products & Solutions, at IQVIA. “IQVIA empowers industry professionals with a leading Enterprise Quality Management solution that accelerates the provision of safe and effective care globally. This award is a testament to our focus on driving innovation and simplifying complex processes for our customers.”
“IQVIA’s differentiated strategy combines intelligence-driven simplification, integration and automation to transform quality operations and drive efficiency for QA/RA professionals,” said Sankara Narayanan, industry director at Frost & Sullivan. “With tailored, customer-centric solutions that leverage AI to streamline workflows, provide insights into individual activities and drive operational improvements, IQVIA prioritizes patient safety and enhances commercial performance.”
Discover how SmartSolve can enhance your quality management processes by visiting our website. Read Frost & Sullivan’s full report here to learn more about IQVIA’s recognition and the benefits of the SmartSolve platform.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240919580830/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
Source: IQVIA
FAQ
What award did IQVIA receive from Frost & Sullivan in 2024?
What is SmartSolve and how does it benefit IQVIA's customers?
How does IQVIA's Healthcare-grade AI contribute to SmartSolve's effectiveness?
What strategy does IQVIA use to transform quality operations for its customers?
